Status:
RECRUITING
Pancreatic Cancer Evolution Upon Treatment
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This project aims at evaluating the different subtypes of pancreatic cancer on EUS-tissue acquisition of pancreatic cancer patients, and their possible modifications throughout time. The study takes a...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Willing to sign informed consent
- Patient with CT scan or MRI or EUS defining the lesion as locally advanced
- Patient who already underwent EUS-TA for solid lesion of the pancreas positive for pancreatic ductal adenocarcinoma (PDAC)
- Patient undergoing neoadjuvant chemotherapy
- Patient primarily followed at San Raffaele Hospital
Exclusion
- Patients not willing to sign informed consent
- Pregnancy and breastfeeding
- Cytology positive for malignancies other than PDAC
- Patient undergoing progression at re-staging CT scan
Key Trial Info
Start Date :
July 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05195281
Start Date
July 14 2021
End Date
December 31 2025
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele Hospital
Milan, Italy, 20132